The good performance of CDMOs on the stock markets. - PHARMAnetwork news
Top 10 Medical Contract Manufacturing Organisations: 2018 | Pharma IQ
US The “Destination” For Outsourcing Will CDMO Capacity Hold Up
Strong CMO/CDMO Market outlook for 2016, but beware moderating factors | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology
Gene therapy manufacturers
Introducing The Medicine Maker Company of the Year Awards
Biologics CDMO Trends and Opportunities in China | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services
From CMO to CDMO: Opportunities for Specializing and Innovation - BioProcess InternationalBioProcess International
Leading CDMO companies by number of acquisitions 2012-2016 | Statista
Top 10 Pharma Companies By Pipeline Size 2019 | M A N O X B L O G
Top 10 reliable Vietnam pharmaceutical companies in 2020 ( Vietnamreport)
Company Introduction-Leadingpharm
Top 5 CDMOs hold 15% of the market as industry consolidation is expected to continue
Top 10 Medical Contract Manufacturing Organisations: 2018 | Pharma IQ
AbbVie/Allergan merger outlook: AbbVie to acquire Allergan for $63 billion.
Global Database of Cell and Gene Therapy CMOs & CDMOs, 2022
Pharmaceutical CDMO Market | 2022 - 27 | Industry Share, Size, Growth - Mordor Intelligence
Top 5 CDMOs hold 15% of the market as industry consolidation is expected to continue
CDMOs/CMOS: The Movers and Shakers of 2021 - DCAT Value Chain Insights
Top pharma industry predictions for 2021
Strong CMO/CDMO Market outlook for 2016, but beware moderating factors | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology
Pharma: Expand CMO/CDMO Business at Medreich
Key Trends Observed in the Top CDMO Companies by jamesseb - Issuu
Global Market Study on CMO/CDMO Biotechnology: Standalone Services to Remain Highly Preferred across Regions
